Clinical trial
Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19)
NCT04344431 is registered in ClinicalTrials.gov with Direction Centrale du Service de Santé des Armées as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19)
- Lead sponsor
- Direction Centrale du Service de Santé des Armées
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- April 14, 2020
- Completion date
- April 30, 2022
- Enrollment
- 100 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.